Therapeutic Benefits of N-Acetylcysteine in the Management of Contrast-Induced Nephropathy
Journal of Health and Allied Sciences NU · 01.10.2024 · 14 (04) · 527-531
DOI: 10.1055/s-0044-1779614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health and Allied Sciences NU, erschienen am 01.10.2024. Verfasst von Sivakumar Velusamy und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to assess the beneficial effects of N-acetylcysteine (NAC) in the treatment of contrast-induced nephropathy (CIN). Materials and Methods A prospective study was conducted in the department of cardiology of a tertiary health care hospital. A sample of 100 patients who had developed CIN through coronary angioplasty were categorized into two groups: one group treated with intravenous fluids (IVF) monotherapy and the other group treated with the combination of IVF and NAC therapy. Statistical Analysis The data were analyzed using statistical software SPSS software version 26 and statistical significance was set at p < 0.05. Independent t-test and paired t-test were used to analyze the parameters.
Results
The rate of incidence of CIN was found to be 10%. We observed that the IVF + NAC combination therapy significantly decreases the serum creatinine compared to IVF monotherapy (p = 0.004). Both therapies show similar treatment outcomes with no significant difference (p = 0.556) in the case of estimated glomerular filtration rate (eGFR). Based on creatinine clearance, the results show adding NAC does not impact any additional benefits (p = 000). The duration of hospital stay of the NAC group was reduced significantly (p = 0.000).
Conclusion
At present, we found that the treatment outcomes which we analyzed based on factors such as serum creatinine, eGFR, and creatinine clearance, are too inconsistent to conclude the beneficial effect of NAC in the management of CIN.
Zitieren
APA
Velusamy, S., Parthasarathy, R., Jayakumar, J., & Parthiban, D. (2024). Therapeutic Benefits of N-Acetylcysteine in the Management of Contrast-Induced Nephropathy. Journal of Health and Allied Sciences NU, 14(04), 527-531. https://doi.org/10.1055/s-0044-1779614
Vancouver
Velusamy S, Parthasarathy R, Jayakumar J, Parthiban D. Therapeutic Benefits of N-Acetylcysteine in the Management of Contrast-Induced Nephropathy. Journal of Health and Allied Sciences NU. 2024;14(04):527-531. doi:10.1055/s-0044-1779614
BibTeX
@article{Velusamy2024,
author = {Velusamy, Sivakumar and Parthasarathy, Rama and Jayakumar, Jessica and Parthiban, Dharshini},
title = {Therapeutic Benefits of N-Acetylcysteine in the Management of Contrast-Induced Nephropathy},
journal = {Journal of Health and Allied Sciences NU},
year = {2024},
volume = {14},
number = {04},
pages = {527--531},
doi = {10.1055/s-0044-1779614}
}
EUVIMED